Bafna Pharmaceuticals

Bafna Pharmaceuticals forayed into the pharmaceutical manufacturing industry, way back in 1981 and consistent drive and determination of Mr. Bafna Mahaveer Chand to expand horizons resulted in the metamorphosis of Bafna Pharmaceuticals into a Public Limited Company in 1995.

Mr. BAFNA MAHAVEER CHAND - CEO, Bafna Pharmaceuticals Ltd., has over three decades of experience in the Pharmaceutical Industry.

A doyen in the industry, with in-depth know-how and expertise of all the faculties & operations of the industry.

His consistent drive and determination to expand the horizons has resulted in different stages of metamorphosis of Bafna Pharmaceuticals from an Institutional supplier to becoming a Generic player and then to Branded Generics and finally to acquiring and creating Brands.

In 2011, he made his dream come true by acquiring Raricap from Johnson & Johnson Ltd. This brand has a legacy of over 42 years and was marketed globally.

Mr. Bafna has overseen the launch of Raricap and its extensions in Sri Lanka and Singapore. He is now looking to launch Raricap in about 100 countries including the USA, UK, Philippines, Vietnam and CIS countries in the next 18 months.

Bafna Pharmaceuticals has expanded its operations and set up manufacturing facilities in Chennai, India, with UK-MHRA & TGA- Australia accreditations, with round the year exports to prestigious Regulated Markets and Emerging markets. More than three decades have passed since the company’s inception, yet the drive to innovate and exceed expectations remains unsurpassed.

Bafna Pharmaceuticals has received Best Supplier Award from the Government of Sri Lanka, Gold Quality Excellence Award 2009, and Quality Excellence Award 2010 from IDMA and Excellence Award 2011 from IES. Mr. Bafna has received The National Level Entrepreneurship Excellence Award in 2010 from the SME Chamber of India, Udyog Rattan Award 2011 and Pioneers 2012 Award from “The Times Award” for his Contribution towards the success of Healthcare in Tamil Nadu.